Valued at USD 2.50 Billion in 2024, the CAR T-cell therapy market is driven by increasing cancer cases worldwide. Forecasted to grow at a CAGR of 15.20% during 2025-2034, the market is likely to expand from USD 2.9 Billion in 2025 to USD 10.29 Billion by 2034, highlighting rapid adoption of advanced therapies. https://www.expertmarketresearch.com/reports/car-t-cell-therapy-market